-
The Rise of RNA Medicines
From rejection to center stage
-
Momentum You Can Feel
On resilience, motion, and the real impact of JPM
-
The Infrastructure We Don't See
Cell therapies, ecosystems, and why innovation endures
-
Why In Vivo Therapies are Taking the Center Stage
Rewriting the CAR-T cell playbook
-
What Kahneman Would Say About Your Next Biotech Deal
A disciplined framework for investing in cell therapies without falling prey to biases
-
The Rise (and Limits) of AAV in Gene Therapy
The gene therapy vector that’s everywhere, but still has so far to go
-
Access in the Next Frontier in Cell Therapy
A personal reflection on innovation, access, and the undeniable investment opportunity in delivering cell therapies at scale
-
Cell Therapies vs. Neurodegeneration
A personal story and where I see breakthroughs making the leap from labs to lives
-
The Scalability Signal: When Pharma Pounces
Why platform technologies may be the scale engine biotech's been waiting for
-
Are Cell Therapies at an Inflection Point?
Breakthroughs in cell therapy are accelerating – here's where investors should look beyond the hype
